Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Head of External Research at Rebiotix, Inc.
Ken Blount, PhD, is a seasoned entrepreneur and director of collaborative research in biotech, pharma, clinical, and academia, and his scientific expertise includes microbiome and small-molecule therapeutic development, translational medical oncology, and RNA-targeting therapeutics. Dr. Blount is the Head of External Research at Rebiotix, where he is cultivating a portfolio of novel microbiome therapeutic programs and directing the internal R&D team. Prior to joining Rebiotix, Dr. Blount directed translational oncology research at the Yale Cancer Center and was a cofounder and Director of Biology at BioRelix, a venture-backed company that developed new antibiotics for a novel RNA target class.